Full Text View
Tabular View
No Study Results Posted
Related Studies
An Open Label Study to Evaluate the Safety and Efficacy of Two Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
This study is ongoing, but not recruiting participants.
Study NCT01565668   Information provided by Astellas Pharma Inc

First Received on March 27, 2012.   Last Updated on May 16, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia, Myeloid, Acute
Additional conditions recognized in this trial
Leukemia
Leukemia, Myeloid
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
AC220
Sponsors listed in this trial
Astellas Pharma Global Development, Inc.
Ambit Biosciences Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services